127 related articles for article (PubMed ID: 37907263)
1. The Mulher Study: cervical cancer screening with primary HPV testing in Mozambique.
Salcedo MP; Lathrop E; Osman N; Neves A; Rangeiro R; Mariano AAN; Nkundabatware JC; Tivir G; Carrilho C; Monteiro ECS; Burny R; Thomas JP; Carns J; Andrade V; Mavume C; Paulo Mugolo R; Atif H; Hoover H; Chivambo E; Chissano M; Oliveira C; Milan J; Varon ML; Fellman BM; Baker E; Jeronimo J; Castle PE; Richards-Kortum R; Schmeler KM; Lorenzoni C
Int J Gynecol Cancer; 2023 Dec; 33(12):1869-1874. PubMed ID: 37907263
[TBL] [Abstract][Full Text] [Related]
2. The Capulana study: a prospective evaluation of cervical cancer screening using human papillomavirus testing in Mozambique.
Salcedo MP; Oliveira C; Andrade V; Mariano AAN; Changule D; Rangeiro R; Monteiro ECS; Baker E; Phoolcharoen N; Varon ML; Thomas JP; Castle PE; Fregnani JHTG; Schmeler KM; Lorenzoni C
Int J Gynecol Cancer; 2020 Sep; 30(9):1292-1297. PubMed ID: 32737122
[TBL] [Abstract][Full Text] [Related]
3. Prospective cohort study examining cervical cancer screening methods in HIV-positive and HIV-negative Cambodian Women: a comparison of human papilloma virus testing, visualization with acetic acid and digital colposcopy.
Thay S; Goldstein A; Goldstein LS; Govind V; Lim K; Seang C
BMJ Open; 2019 Feb; 9(2):e026887. PubMed ID: 30804036
[TBL] [Abstract][Full Text] [Related]
4. Screening approaches for cervical cancer in Mozambique in HIV positive and negative women.
Sineque A; Catalao C; Ceffa S; Fonseca AM; Parruque F; Guidotti G; Massango C; Carrilho C; Bicho C; Rangeiro R; Orlando S; Marazzi MC; Lorenzoni C; Ciccacci F
Eur J Cancer Prev; 2023 Sep; 32(5):431-437. PubMed ID: 37144587
[TBL] [Abstract][Full Text] [Related]
5. Expanding Cervical Cancer Screening in Mozambique: Challenges Associated With Diagnosing and Treating Cervical Cancer.
Batman S; Rangeiro R; Monteiro E; Changule D; Daud S; Ribeiro M; Tsambe E; Bila C; Osman N; Carrilho C; Neves A; Atif H; De Jesus C; Mariano A; Moretti-Marques R; Vieira M; Fontes-Cintra G; Lopes A; Batware JC; Luis E; Grover S; Baker E; Fellman B; Montealegre J; Castle PE; Jeronimo J; Chiao E; Lorenzoni C; Schmeler K; Salcedo MP
JCO Glob Oncol; 2023 Sep; 9():e2300139. PubMed ID: 37824802
[TBL] [Abstract][Full Text] [Related]
6. Upscaling cervical cancer screening and treatment for women living with HIV at a rural referral hospital in Tanzania: protocol of a before-and-after study exploring HPV testing and novel diagnostics.
Di Salvo I; Mnzava D; Nicoletti GJ; Senkoro E; Ndege RC; Huang DJ; Makunja NT; Kassiga GI; Kaufmann AM; Weisser M; Kind AB
BMC Health Serv Res; 2023 Mar; 23(1):234. PubMed ID: 36894985
[TBL] [Abstract][Full Text] [Related]
7. Uptake of community-based, self-collected HPV testing vs. visual inspection with acetic acid for cervical cancer screening in Kampala, Uganda: preliminary results of a randomised controlled trial.
Moses E; Pedersen HN; Mitchell SM; Sekikubo M; Mwesigwa D; Singer J; Biryabarema C; Byamugisha JK; Money DM; Ogilvie GS
Trop Med Int Health; 2015 Oct; 20(10):1355-67. PubMed ID: 26031572
[TBL] [Abstract][Full Text] [Related]
8. Self-collection based HPV testing for cervical cancer screening among women living with HIV in Uganda: a descriptive analysis of knowledge, intentions to screen and factors associated with HPV positivity.
Mitchell SM; Pedersen HN; Eng Stime E; Sekikubo M; Moses E; Mwesigwa D; Biryabarema C; Christilaw J; Byamugisha JK; Money DM; Ogilvie GS
BMC Womens Health; 2017 Jan; 17(1):4. PubMed ID: 28086933
[TBL] [Abstract][Full Text] [Related]
9. Screening of cervical neoplasia in HIV-infected women in India.
Joshi S; Sankaranarayanan R; Muwonge R; Kulkarni V; Somanathan T; Divate U
AIDS; 2013 Feb; 27(4):607-15. PubMed ID: 23079814
[TBL] [Abstract][Full Text] [Related]
10. Performance of visual Inspection With Acetic Acid for Cervical Cancer Screening as Compared to Human papillomavirus Deoxyribonucleic acid Testing Among Women With HIV in Ethiopia: A Comparative Cross-sectional Study.
Bogale AL; Teklehaymanot T; Kassie GM; Medhin G; Ali JH; Belay NB
Cancer Control; 2022; 29():10732748221114980. PubMed ID: 35829643
[TBL] [Abstract][Full Text] [Related]
11. Point-of-care HPV DNA testing of self-collected specimens and same-day thermal ablation for the early detection and treatment of cervical pre-cancer in women in Papua New Guinea: a prospective, single-arm intervention trial (HPV-STAT).
Vallely AJB; Saville M; Badman SG; Gabuzzi J; Bolnga J; Mola GDL; Kuk J; Wai M; Munnull G; Garland SM; Brotherton JML; Kelly-Hanku A; Morgan C; Toliman PJ; Kombati Z; Kariwiga G; Babona D; Tan G; Simms KT; Cornall AM; Tabrizi SN; Wand H; Guy R; Canfell K; Kaldor JM
Lancet Glob Health; 2022 Sep; 10(9):e1336-e1346. PubMed ID: 35878625
[TBL] [Abstract][Full Text] [Related]
12. Integrated cervical cancer screening in Mayuge District Uganda (ASPIRE Mayuge): a pragmatic sequential cluster randomized trial protocol.
Nakisige C; Trawin J; Mitchell-Foster S; Payne BA; Rawat A; Mithani N; Amuge C; Pedersen H; Orem J; Smith L; Ogilvie G
BMC Public Health; 2020 Jan; 20(1):142. PubMed ID: 32005202
[TBL] [Abstract][Full Text] [Related]
13. Screening for cervical cancer among HIV-positive and HIV-negative women in Cameroon using simultaneous co-testing with careHPV DNA testing and visual inspection enhanced by digital cervicography: Findings of initial screening and one-year follow-up.
Cholli P; Bradford L; Manga S; Nulah K; Kiyang E; Manjuh F; DeGregorio G; Ogembo RK; Orock E; Liu Y; Wamai RG; Sheldon LK; Gona PN; Sando Z; Welty T; Welty E; Ogembo JG
Gynecol Oncol; 2018 Jan; 148(1):118-125. PubMed ID: 29153541
[TBL] [Abstract][Full Text] [Related]
14. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus testing using existing nucleic acid testing platforms to screen women for cervical cancer: implementation studies from five sub-Saharan African countries.
Joseph J; Demke O; Ameyan L; Bitilinyu-Bango J; Bourgoin B; Diop M; Guèye B; Kama J; Lubega M; Madzima B; Maparo T; Mhizha T; Musoke A; Nabadda S; Phiri T; Tchereni T; Wiwa O; Hariharan K; Peter T; Khan S
BMJ Open; 2023 Jan; 13(1):e065074. PubMed ID: 36609331
[TBL] [Abstract][Full Text] [Related]
16. PCR-reverse dot blot human papillomavirus genotyping as a primary screening test for cervical cancer in a hospital-based cohort.
Kang Y; Sun P; Mao X; Dong B; Ruan G; Chen L
J Gynecol Oncol; 2019 May; 30(3):e29. PubMed ID: 30887754
[TBL] [Abstract][Full Text] [Related]
17. Feasibility of a community-based cervical cancer screening with "test and treat" strategy using self-sample for an HPV test: Experience from rural Cameroon, Africa.
Fokom Domgue J; Futuh B; Ngalla C; Kakute P; Manjuh F; Manga S; Nulah K; Welty E; Schmeler K; Welty T
Int J Cancer; 2020 Jul; 147(1):128-138. PubMed ID: 31633801
[TBL] [Abstract][Full Text] [Related]
18. HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer.
Wright TC; Denny L; Kuhn L; Pollack A; Lorincz A
JAMA; 2000 Jan; 283(1):81-6. PubMed ID: 10632284
[TBL] [Abstract][Full Text] [Related]
19. [A study of cervical cancer screening algorithms].
Zhao FH; Zhang WH; Pan QJ; Zhang X; Chen W; Liu B; Ma JF; Hu SY; Qiao YL
Zhonghua Zhong Liu Za Zhi; 2010 Jun; 32(6):420-4. PubMed ID: 20819481
[TBL] [Abstract][Full Text] [Related]
20. HPV testing compared with routine cytology in cervical screening: long-term follow-up of ARTISTIC RCT.
Gilham C; Sargent A; Kitchener HC; Peto J
Health Technol Assess; 2019 Jun; 23(28):1-44. PubMed ID: 31219027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
